Results 81 to 90 of about 46,995 (245)
ABSTRACT Background Cutaneous warts are common benign lesions caused by human papillomavirus and often resist conventional treatments. Intralesional immunotherapy with measles–mumps–rubella (MMR) vaccine or vitamin D3 has emerged as an alternative, but their comparative efficacy and safety remain unclear.
Rahul Balach +9 more
wiley +1 more source
Protective effect of vaccination against mumps complications, Czech Republic, 2007–2012
Background In the Czech Republic, two-dose immunization against mumps achieves 98 % coverage. The routine reporting detects mumps cases, clinical complications, and hospital admissions in unvaccinated but also in vaccinated individuals.
Hana Orlíková +6 more
doaj +1 more source
Anticipating Knowledge Applicability in Open Science Through Recycling, Mimicking, and Shortcutting
ABSTRACT Open science literature scrutinizes how organizations provide access to knowledge. Yet, much less is known about how organizations pursuing open science for societal impact anticipate knowledge applicability—that shared knowledge is reusable for other organizations and individuals, and enables open social innovation.
Konstantin Hondros +3 more
wiley +1 more source
Measles and rubella are targeted for elimination in the WHO region Europe. To reach the elimination goal, vaccination coverage of 95% must be achieved and sustained, the genotype information has to be provided for 80% of all outbreaks and transmission ...
Katharina Hueppe +4 more
doaj +1 more source
To analyze epidemiological characteristics of mumps in different periods and explore the impact of different immunization strategies of mumps containing vaccine (MuCV) on the incidence of mumps in Quzhou.
Canya Fu +6 more
doaj +1 more source
Mumps outbreak in the Federation of Bosnia and Herzegovina with large cohorts of susceptibles and genetically diverse strains of genotype G, Bosnia and Herzegovina, December 2010 to September 2012 [PDF]
Mirsada Hukić +10 more
openalex +1 more source
Immunogenicity and safety of intramuscular versus subcutaneous administration of a combined measles, mumps, rubella, and varicella vaccine to children 12 to 18 months of age [PDF]
H. Haas +5 more
openalex +1 more source
Measles, Mumps, Rubella serology in juvenile idiopathic arthritis [PDF]
M.W. Heijstek +4 more
openalex +1 more source
Despite the provision of a mumps vaccination program in Canada for over three decades, mumps has not reached elimination. Instead, a re-emergence has been observed in vaccinated populations, particularly in young adults.
Jasmine Rae Frost +8 more
doaj +1 more source

